Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypoglycemic Agents”

208 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 208 results

Not applicableStudy completedNCT00351234
What this trial is testing

Carnitine Levels and Carnitine Supplementation in Type I Diabetes

Who this might be right for
Diabetes Mellitus, Type IHypoglycemia
Children's Mercy Hospital Kansas City 200
Not applicableUnknownNCT05819671
What this trial is testing

Prevalence of Upper Limb Musculoskeletal Abnormalities in Type 2 Diabetic Patients and Its Relation to Hypoglycemic Control.

Who this might be right for
Upper Limb Musculoskeletal Abnormalities
Eslam Elsayed Ali Shohda 400
Large-scale testing (Phase 3)Study completedNCT00859898
What this trial is testing

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 1,093
Testing effectiveness (Phase 2)Study completedNCT02408705
What this trial is testing

Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects

Who this might be right for
Type 1 Diabetes Mellitus
Medical University of Graz 14
Not applicableUnknownNCT04184440
What this trial is testing

The Hypoglycemic Effect of Cyclocarya Paliurus Extract on Hyperglycemic Populations

Who this might be right for
Hyperglycemia
Huazhong University of Science and Technology 150
Large-scale testing (Phase 3)Study completedNCT04809220
What this trial is testing

Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+4 more
Eli Lilly and Company 591
Early research (Phase 1)Study completedNCT04907019
What this trial is testing

A Drug Interaction Study of SY-004 Capsules in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Suzhou Yabao Pharmaceutical R&D Co., Ltd. 24
Not applicableEnded earlyNCT02485132
What this trial is testing

Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea

Who this might be right for
Type 2 Diabetes
Institut de Recherches Cliniques de Montreal 2
Post-approval studies (Phase 4)Study completedNCT04237493
What this trial is testing

Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan

Who this might be right for
Diabetes Mellitus, Type 2
University of Jordan 687
Large-scale testing (Phase 3)Study completedNCT00603291
What this trial is testing

BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus

Who this might be right for
Obesity
Eisai Inc. 604
Not applicableStudy completedNCT00687284
What this trial is testing

Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,188
Not applicableStudy completedNCT02278068
What this trial is testing

COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy

Who this might be right for
DiabetesEndocrine, Nutritional and Metabolic Diseases (E00-E89)
Metavention 46
Post-approval studies (Phase 4)Study completedNCT01378117
What this trial is testing

Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusHospitalizationHyperglycemia
Emory University 90
Not applicableStudy completedNCT00315939
What this trial is testing

Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Boris Kovatchev, PhD 120
Large-scale testing (Phase 3)Study completedNCT04409795
What this trial is testing

Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study

Who this might be right for
Type 1 DiabetesMonogenic Diabetes
Joslin Diabetes Center 3
Not applicableStudy completedNCT02476760
What this trial is testing

Incretin-based Drugs and Acute Pancreatitis

Who this might be right for
Diabetes Mellitus, Type 2
Canadian Network for Observational Drug Effect Studies, CNODES 1,417,914
Not applicableUnknownNCT02671864
What this trial is testing

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 7,200
Early research (Phase 1)Ended earlyNCT01238224
What this trial is testing

Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Vastra Gotaland Region 22
Large-scale testing (Phase 3)Study completedNCT00528879
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 915
Large-scale testing (Phase 3)UnknownNCT00994149
What this trial is testing

Diazoxide In the Management Of Hypoglycemic Neonates

Who this might be right for
Infant, Newborn, DiseasesPregnancy in DiabeticsInfant, Diabetic Mother+2 more
University of Saskatchewan 100
Load More Results